Eugenio Battaglia

Eugenio Battaglia

Oct 17, 2014

Group 6 Copy 231
-1
    Please wait...

    About This Project

    BioPeers – Peers Center for Biotech and Society
    Our bodies produce very low doses of N,N-Dimethyltryptamine (DMT), a psychotropic substance. Recent findings suggest that DMT is an important modulator of Sig-1R, a receptor that plays important roles in neuropsychiatric diseases like schizophrenia, and depression. This project aims to further develop a hypothesis for the relation between DMT and Sig-1R, in hopes of providing novel insight into these neuropsychiatric diseases.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can a rabies vaccination booster save African Wild Dogs?

    Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Backer Badge Funded